Last update 08 May 2025

Wuhan Tonghua Technology Development Co., Ltd.

Dissolved
| Private Company|2011|Hubei Sheng, China

Overview

Related

1
Drugs associated with Wuhan Tonghua Technology Development Co., Ltd.
Yipanzhu Granules
Target-
Mechanism-
Active Org.-
Originator Org.
Wuhan Tonghua Technology Development Co., Ltd.
Active Indication-
Inactive Indication
Soft Tissue Injuries
Drug Highest PhaseSuspended
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Wuhan Tonghua Technology Development Co., Ltd.
CTR20131967
/ SuspendedPhase 2
一盘珠颗粒与安慰剂对照治疗急性软组织损伤（气滞血瘀证）随机、双盲、多中心临床研究
[Translation] A randomized, double-blind, multicenter clinical study of Yipanzhu granules versus placebo in the treatment of acute soft tissue injury (Qi stagnation and blood stasis syndrome)
100 Clinical Results associated with Wuhan Tonghua Technology Development Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Wuhan Tonghua Technology Development Co., Ltd.
Login to view more data
100 Deals associated with Wuhan Tonghua Technology Development Co., Ltd.
Login to view more data
100 Translational Medicine associated with Wuhan Tonghua Technology Development Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 01 Sep 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Yipanzhu Granules
Soft Tissue Injuries
More
Suspended
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free